Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Medical College of Wisconsin
Medical College of Wisconsin
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
St. Jude Children's Research Hospital
University of California, San Francisco
National Cancer Institute (NCI)
University of California, San Francisco
University of Alabama at Birmingham
Northwestern University
Case Comprehensive Cancer Center